The oral route reduces potential adverse events associated with intravenous (IV) administration but is associated with low bioavailability
doi:10.1080/21551197.2018.1564721 Zhang Y, Chen G, Wang W, Yang D, Zhu D, Jing Y
Cagrilintide was specifically engineered with molecular modifications to resist rapid breakdown in the body and bind effectively to amylin 1 and 3 (AMY1R, AMY3R) receptors in the brain, allowing for a more stable, once-weekly dosing regimen compared to the multiple daily injections required for older amylin analogues like pramlintide
UK Clinical Evidence GLP-1 receptor agonists are increasingly prescribed for type 2 diabetes and weight management in the UK
Additionally, Detoxamin EDTA suppositories are far safer than IV chelation, because the EDTA in the suppositories travels through the body at a much slower rate, which alleviates an undue elimination burden on the liver and kidneys
Some researchers argue that pulsatile peptide delivery, with peaks and troughs in plasma concentration, may produce different receptor signaling patterns than the sustained exposure from weekly injections